---
title: "Chlorpromazine - Psychotic Disorder"
sidebar: mydoc_sidebar
permalink: db00477-mesh-d011618-1.html
toc: false 
---


Path ID: `DB00477_MESH_D011618_1`
{% include image.html url="images/db00477-mesh-d011618-1.png" file="db00477-mesh-d011618-1.png" alt="db00477-mesh-d011618-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D002746 | chlorpromazine | Drug |
| UniProt:P14416 | dopamine D2 receptor | Protein |
| CHEBI:18243 | dopamine | ChemicalSubstance |
| GO:0032225 | regulation of synaptic transmission, dopaminergic | BiologicalProcess |
| UBERON:0001017 | central nervous system | GrossAnatomicalStructure |
| HP:0008760 | violent behavior | PhenotypicFeature |
| MESH:D011618 | Psychotic disorder | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Chlorpromazine | DECREASES ACTIVITY OF | Dopamine D2 Receptor |
| Dopamine D2 Receptor | POSITIVELY CORRELATED WITH | Dopamine |
| Dopamine | CORRELATED WITH | Regulation Of Synaptic Transmission, Dopaminergic |
| Regulation Of Synaptic Transmission, Dopaminergic | LOCATED IN | Central Nervous System |
| Central Nervous System | PREVENTS | Violent Behavior |
| Violent Behavior | CORRELATED WITH | Psychotic Disorder |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB00477](https://go.drugbank.com/drugs/DB00477)
